Daito Pharmaceutical Co.,Ltd. Whats New

We will be exhibiting at 24nd Interphex Japan, June 29th to July 1st 2011

Our company was listed on the 1st section of TSE.

Our company was approved for listing on the 1st section of TSE.

Our company was approved on March 17, 2011 for listing on the 1st section of Tokyo Stock Exchange.

March 11,2011 Effect of the Earthquake in Japan

We sympathize deeply with the sufferers in the Earthquake.

The influence of the Earthquake upon our company is as follows as of today:

1. The Factory

No damage of personnel and facilities and in normal operation.

2. Shipment of Products

Normal conditions of shipment as scheduled except to the damaged area of the North Eastern Japan.

We will have an Exhibition Booth at 45-26 in the 23rd INTERPHEX JAPAN which takes place from June 30th to July 2nd in Tokyo Big Sight.

Our company was listed on the 2nd section of TSE.

Our homepage was renewed.

Our company was approved for listing on the 2nd section of TSE.

Our company was approved on February 19, 2010 for listing on the 2nd section of Tokyo Stock Exchange.

We will be exhibiting at 22nd Interphex Japan, July 1(Wed)-3(Fri) 2009

INTERPHEX JAPAN is the ASIA'S LARGEST pharmaceutical industry event with 1,400 exhibitors and 63,000 visitors. At the venue, business meetings are enthusiastically held between professionals of pharmaceutical manufacturers and exhibitors from all over the world.

During the exhibition, we will present you Daito, the capabilities and the future strategy.

Daito offers integrated production from APIs to dosage froms,outsourcing, and cooperate development. Our facilities are compiled with C-GMP meeting the US FDA and European EMEA standards. Our newly built state of the art APIs and formulations factories enhanced our production capabilities:

API -14m³ crystallization capability,60m³ reaction capability

Formulation-3.6billion tablets, fine grain/granulated powder 900 ton.

Invitation for CPhI Daito Guest Room

PRESS　RELEASE